Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ChiCTR2100045922Phase 4Recruiting
Phase 4, open-label trial of remimazolam, midazolam and propofol in pneumonia (3 arms), sponsored by Affiliated Hospital of Guizhou Medical University. Primary endpoint: Sedation compliance rate. Started May 2021; status: recruiting.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on ChiCTR2100045922.